Moderna and Merck reveal experimental vaccine to prevent skin cancer recurrence
Pharmaceutical companies Moderna and MSD (known as Merck in the US and Canada) have made a joint announcement in a press release about a vaccine treatment to patients who have undergone melanoma (skin cancer) that can prevent it from returning or spreading, an adjuvant therapy af…